<bill session="109" type="s" number="3695" updated="2023-01-12T17:52:28Z">
  <state datetime="2006-07-19">REFERRED</state>
  <status>
    <introduced datetime="2006-07-19"/>
  </status>
  <introduced datetime="2006-07-19"/>
  <titles>
    <title type="display">A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.</title>
  </titles>
  <sponsor bioguide_id="R000361"/>
  <cosponsors>
    <cosponsor bioguide_id="K000305" joined="2006-09-07"/>
    <cosponsor bioguide_id="L000174" joined="2006-07-19"/>
    <cosponsor bioguide_id="S000148" joined="2006-07-19"/>
  </cosponsors>
  <actions>
    <action datetime="2006-07-19">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2006-07-19">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S7927"/>
    </action>
    <action datetime="2006-07-19" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S7928" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="109" type="h" number="5993" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Generic drugs"/>
  </subjects>
  <amendments/>
  <summary date="2006-09-20T18:04:31Z" status="Introduced in Senate">Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from manufacturing, marketing, selling, or distributing a generic version of such drug during any exclusivity period granted to manufacturers of generic brands.</summary>
</bill>
